CLDN5 and breast cancer: Downregulating miR-202-3p enhanced the transmigration ability of breast cancer cells across the BE by mediating the expression of MMP1, which in turn degraded inter-endothelial protein junctions, ZO-1, claudin-5 and β-catenin.